Gene deletion of CHKB is also detected in DLBCL (~4–6%) and pediatric ALL (~1%), while amplification and mutation of CHKB are very rare in human lymphoid malignancies (Figure 1B). This evidence concerns the gene CHKB and acute lymphoblastic leukemia.